Evaluating your likely current (and near future) state of health means taking into account the risk factors — such as non-human estrogen use — that affect you. Our medical diagnosis tool, The Analyst™, identifies major risk factors by asking the right questions.
Have you used non-human estrogens (such as Premarin, Estrace, or Prempro)? In the past, it may have been referred to as HRT (Hormone Replacement Therapy).
Possible responses:→ No / don't know
→ For under 5 years, but not any more
→ For 5 or more years, but not any more
→ Current use for under 5 years
→ Current use for 5 or more years
Recent findings from a landmark study, published in The New England Journal of Medicine in 1995 and involving 121,700 women, revealed startling effects from non-human estrogen use. It warned that women who used this type of estrogens to offset the symptoms of menopause also increased their chance of developing breast cancer by 30-40% by taking the hormone for more than five years. In women aged between 60 and 64, the risk of breast cancer rose to 70% after five years of use. Finally, the study concluded that women were 45% more likely to die from breast cancer than those who chose not to use them or used them for less than five years.
In 1975, The New England Journal of Medicine examined the rates of endometrial cancer for estrogen consumers, concluding that the risk was seven and a half times greater for estrogen users. Women who had used estrogen for seven years or longer were 14 times more likely to develop cancer. [Coney, Sandra, The Menopause Industry, Spinifex Press Pty Ltd., Australia, 1991, pp.164-5]
Taking non-human estrogens after menopause doubles the risk of gallbladder disease.